Search hospitals > Louisiana > Metairie
LSU Healthcare Network / Metairie Multi-Specialty Clinic
Claim this profileMetairie, Louisiana 70006
Global Leader in Prostate Cancer
Global Leader in Bladder Cancer
Conducts research for Kidney Cancer
Conducts research for Renal Cell Carcinoma
Conducts research for Prostate Adenocarcinoma
39 reported clinical trials
7 medical researchers
Summary
LSU Healthcare Network / Metairie Multi-Specialty Clinic is a medical facility located in Metairie, Louisiana. This center is recognized for care of Prostate Cancer, Bladder Cancer, Kidney Cancer, Renal Cell Carcinoma, Prostate Adenocarcinoma and other specialties. LSU Healthcare Network / Metairie Multi-Specialty Clinic is involved with conducting 39 clinical trials across 136 conditions. There are 7 research doctors associated with this hospital, such as Scott E. Delacroix, Augusto C. Ochoa, Amelia Jernigan, MD, and Rajasree P. Chowdry.Area of expertise
1Prostate Cancer
Global LeaderStage IV
PD-L1 positive
BRCA1 positive
2Bladder Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Scott E. DelacroixLSU Healthcare Network / Metairie Multi-Specialty Clinic5 years of reported clinical research
Expert in Prostate Cancer
Studies Bladder Cancer
28 reported clinical trials
63 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Breast cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Amelia Jernigan, MDUniversity Medical Center New Orleans2 years of reported clinical research
Studies Ovarian Cancer
Studies Cervical Cancer
9 reported clinical trials
20 drugs studied
Rajasree P. ChowdryUniversity Medical Center New Orleans2 years of reported clinical research
Studies Renal Cell Carcinoma
Studies Kidney Cancer
5 reported clinical trials
16 drugs studied
Clinical Trials running at LSU Healthcare Network / Metairie Multi-Specialty Clinic
Prostate Cancer
Kidney Cancer
Bladder Cancer
Bladder Carcinoma
Ovarian Cancer
Uterine Cancer
Renal Cell Carcinoma
Kidney Carcinoma
Prostate Adenocarcinoma
Cancer
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting2 awards Phase 3
Carboplatin Before Surgery
for Prostate Cancer
This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping, or slowing the growth of tumor cells. Giving carboplatin before surgery may shrink tumors in patients with high-risk prostate cancer with BRCA1 and BRCA2 gene mutations.
Recruiting1 award Phase 210 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at LSU Healthcare Network / Metairie Multi-Specialty Clinic?
LSU Healthcare Network / Metairie Multi-Specialty Clinic is a medical facility located in Metairie, Louisiana. This center is recognized for care of Prostate Cancer, Bladder Cancer, Kidney Cancer, Renal Cell Carcinoma, Prostate Adenocarcinoma and other specialties. LSU Healthcare Network / Metairie Multi-Specialty Clinic is involved with conducting 39 clinical trials across 136 conditions. There are 7 research doctors associated with this hospital, such as Scott E. Delacroix, Augusto C. Ochoa, Amelia Jernigan, MD, and Rajasree P. Chowdry.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.